Marisleep Retard Drops
Prolonged-Release Melatonin for Insomnia
MARISLEEP RETARD DROPS is a dietary supplement (FS) in oral drops format, specifically formulated for managing insomnia and sleep disorders in infants, children, and adolescents. Its distinctive feature is the Melatonin in prolonged-release Microgranules (Prolonged + Retard).
This innovative technology ensures a biphasic action: approximately 50% of Melatonin is released within the first hour, promoting rapid sleep onset, while over 75% is released within 4 hours.
This delayed release profile ensures that Melatonin’s effect extends for a longer duration, thus supporting overall sleep quality and duration. The product features a sweet and pleasant taste and easy administration.
Therapeutic indications:
- Childhood insomnia.
- Reduction in time needed to fall asleep.
- Promotes sleep quality and duration.
- Sleep disorders in adolescents
- Supportive use for sleep disorders in cases of Autism Spectrum Disorders (ASD).
FarmaImpresa Group, a certified dietary supplement manufacturer, offers MARISLEEP RETARD DROPS as ready to market or available for private label, with full technical and regulatory support.
